article thumbnail

CFO Corner With SCHOTT Pharma’s Almuth Steinkühler

Global Finance

Almuth Steinkhler has been CFO of SCHOTT Pharma, which designs drug containment products and drug delivery systems for pharmaceutical and biotech companies, since August 2022. Originally a division of glass manufacturer Schott AG, the company went public on the Frankfurt Stock Exchange in 2023.

CFO 52
article thumbnail

Member Profile: Jithan Bridgmohan

CFO Talks

With a strong foundation as a Chartered Accountant and an MBA in International Business, Jithan has held senior leadership roles in pharmaceuticals, FMCG, printing, engineering, and textiles, spanning five continents.

CFO 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CFO Corner: Anne-Laure Autret-Cornet, OSE Immunotherapeutics

Global Finance

And we have ongoing important collaborations with other companies such as Boehringer Ingelheim and Veloxis Pharmaceuticals. This involves the development of OSE-230, a novel monoclonal antibody, and included an upfront payment of $48 million with potential milestone payments and royalties.

CFO 52
article thumbnail

Moore Kingston Smith advises Asteria Group on latest acquisition

Accountancy Today

Moore Kingston Smiths corporate finance team has advised Asteria Labels and Packaging Group once again to advise on its acquisition of Dublin-based printing company Label World. The firms corporate finance team advised on financial and tax due diligence.

article thumbnail

FCF Pharmaceutical Market Study – 2022

Fox Corporate Finance

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Pharmaceutical Market Study – 2022”. Based on available data from European pharmaceutical providers, the FCF Pharmaceutical Market Study is a detailed and comprehensive.

article thumbnail

FCF Pharmaceutical Market Study – 2021 published

Fox Corporate Finance

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Pharmaceutical Market Study – 2021”. Based on available data from European pharmaceutical providers, the FCF Pharmaceutical Market Study is a detailed and comprehensive.

article thumbnail

FRP Corporate Finance advises Kelso Pharma on Alturix acquisition

Accountancy Today

The FRP Corporate Finance debt advisory team has supported pan-European specialist pharmaceutical business, Kelso Pharma (Kelso), on its acquisition of Alturix, a UK pharmaceutical company specialising in developing and commercialising originator and niche branded generics.